These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9761270)

  • 21. Rapid urine drug screens: diphenhydramine and methadone cross-reactivity.
    Rogers SC; Pruitt CW; Crouch DJ; Caravati EM
    Pediatr Emerg Care; 2010 Sep; 26(9):665-6. PubMed ID: 20838187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing.
    Huestis MA; Cone EJ; Wong CJ; Umbricht A; Preston KL
    J Anal Toxicol; 2000 Oct; 24(7):509-21. PubMed ID: 11043653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Bionike one-step tests for the detection of drugs of abuse in urine.
    Brown ER; Jarvie DR; Simpson D
    Ann Clin Biochem; 1997 Jan; 34 ( Pt 1)():74-80. PubMed ID: 9022891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of GC-MS and EIA results for the analysis of methadone in oral fluid.
    Cooper G; Wilson L; Reid C; Baldwin D; Hand C; Spiehler V
    J Forensic Sci; 2005 Jul; 50(4):928-32. PubMed ID: 16078500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Porous silicon mass spectrometry as an alternative confirmatory assay for compliance testing of methadone.
    Guinan TM; Neldner D; Stockham P; Kobus H; Della Vedova CB; Voelcker NH
    Drug Test Anal; 2017 May; 9(5):769-777. PubMed ID: 27364015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug abuse screening with immunoassays: unexpected cross-reactivities and other pitfalls.
    Colbert DL
    Br J Biomed Sci; 1994 Jun; 51(2):136-46. PubMed ID: 8049611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Cozart microplate ELISA and GC-MS detection of methadone and metabolites in human hair.
    Cooper G; Wilson L; Reid C; Baldwin D; Hand C; Spiehler V
    J Anal Toxicol; 2005 Oct; 29(7):678-81. PubMed ID: 16419400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of an ELISA method for screening methadone in postmortem blood.
    Juhascik M; Habbel S; Barron W; Behonick G
    J Anal Toxicol; 2006 Oct; 30(8):617-20. PubMed ID: 17132262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the Microgenics CEDIA heroin metabolite (6-AM) and the Roche Abuscreen ONLINE opiate immunoassays for the detection of heroin use in forensic urine samples.
    Holler JM; Bosy TZ; Klette KL; Wiegand R; Jemionek J; Jacobs A
    J Anal Toxicol; 2004 Sep; 28(6):489-93. PubMed ID: 15516301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct ELISA kits as a sensitive and selective screening method for abstinence control in urine.
    Kirschbaum KM; Musshoff F; Wilbert A; Röhrich J; Madea B
    Forensic Sci Int; 2011 Apr; 207(1-3):66-9. PubMed ID: 20933345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Opiates].
    Nomoto T
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():469-71. PubMed ID: 15658365
    [No Abstract]   [Full Text] [Related]  

  • 32. Methadone and metabolite urine concentrations in patients maintained on methadone.
    Preston KL; Epstein DH; Davoudzadeh D; Huestis MA
    J Anal Toxicol; 2003 Sep; 27(6):332-41. PubMed ID: 14516485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gatifloxacin interference with opiate urine drug screen.
    Straley CM; Cecil EJ; Herriman MP
    Pharmacotherapy; 2006 Mar; 26(3):435-9. PubMed ID: 16503726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gas chromatography-mass spectrometry confirmation of Cozart RapiScan saliva methadone and opiates tests.
    Moore L; Wicks J; Spiehler V; Holgate R
    J Anal Toxicol; 2001 Oct; 25(7):520-4. PubMed ID: 11599594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postnatal methadone withdrawal syndrome: hair analysis for detecting chronic exposure.
    Papaseit E; Corrales E; Stramesi C; Vall O; Palomeque A; Garcia-Algar O
    Acta Paediatr; 2010 Feb; 99(2):162-3. PubMed ID: 19839962
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of two immunoassay procedures for drug testing in hair samples.
    Musshoff F; Kirschbaum KM; Graumann K; Herzfeld C; Sachs H; Madea B
    Forensic Sci Int; 2012 Feb; 215(1-3):60-3. PubMed ID: 21601388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS.
    Boettcher M; Haenseler E; Hoke C; Nichols J; Raab D; Domke I
    Clin Lab; 2000; 46(1-2):49-52. PubMed ID: 10745981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new highly specific buprenorphine immunoassay for monitoring buprenorphine compliance and abuse.
    Melanson SE; Snyder ML; Jarolim P; Flood JG
    J Anal Toxicol; 2012 Apr; 36(3):201-6. PubMed ID: 22417836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. False-positive methadone urine drug screen in a patient treated with quetiapine.
    Lasić D; Uglesić B; Zuljan-Cvitanović M; Supe-Domić D; Uglesić L
    Acta Clin Croat; 2012 Jun; 51(2):269-72. PubMed ID: 23115954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unusual false-positive case of urinary screening for buprenorphine.
    Lippi G; Romero A; Cervellin G; Mercadanti M
    J Clin Lab Anal; 2011; 25(4):244-5. PubMed ID: 21786326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.